Teva, Endo and more back on the hook in San Francisco opioid trial
Teva, Endo and more back on the hook in San [...]
Merck KGaA pledges $550M in manufacturing upgrades after closing buyout of mRNA CDMO Exelead
Merck KGaA pledges $550M in manufacturing upgrades after closing buyout [...]
‘Major blunder:’ Ex-staffers blast Bristol Myers Squibb’s handling of Breyanzi approval in latest CVR lawsuit update
‘Major blunder:’ Ex-staffers blast Bristol Myers Squibb’s handling of Breyanzi [...]
Novavax begins delivery of its long-delayed COVID-19 vaccine in Europe
Novavax begins delivery of its long-delayed COVID-19 vaccine in Europe [...]
Biohaven lines up rhinosinusitis patients for trial of its migraine med Nurtec ODT
Biohaven lines up rhinosinusitis patients for trial of its migraine [...]
March-in campaign on Pfizer’s prostate cancer med Xtandi gets congressional backing. Will it matter?
March-in campaign on Pfizer’s prostate cancer med Xtandi gets congressional [...]
Novartis’ Leqvio to reap $2.5B by 2027 thanks to convenience edge over Amgen, Sanofi rivals: analyst
Novartis’ Leqvio to reap $2.5B by 2027 thanks to convenience [...]
Sandoz launches generic Revlimid in 19 countries in Europe, opening a flood of competition for BMS’ megablockbuster
Sandoz launches generic Revlimid in 19 countries in Europe, opening [...]
Roche settles lawsuit claiming AstraZeneca’s Ultomiris infringes delivery patent
Roche settles lawsuit claiming AstraZeneca’s Ultomiris infringes delivery patent aliu [...]
Sanofi, Regeneron ditch Dupixent trial vs. Novartis and Roche’s Xolair for hives condition
Sanofi, Regeneron ditch Dupixent trial vs. Novartis and Roche’s Xolair [...]